Cargando…

Irreversible electroporation in primary and metastatic hepatic malignancies: A review

BACKGROUND: Liver cancer makes up a huge percentage of cancer mortality worldwide. Irreversible electroporation (IRE) is a relatively new minimally invasive nonthermal ablation technique for tumors that applies short pulses of high frequency electrical energy to irreversibly destabilize cell membran...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Tianchu, Wang, Xifu, Su, Zhanliang, Shangguan, Junjie, Sun, Chong, Figini, Matteo, Wang, Jian, Yaghmai, Vahid, Larson, Andrew C., Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413217/
https://www.ncbi.nlm.nih.gov/pubmed/28445252
http://dx.doi.org/10.1097/MD.0000000000006386
_version_ 1783233141404598272
author Lyu, Tianchu
Wang, Xifu
Su, Zhanliang
Shangguan, Junjie
Sun, Chong
Figini, Matteo
Wang, Jian
Yaghmai, Vahid
Larson, Andrew C.
Zhang, Zhuoli
author_facet Lyu, Tianchu
Wang, Xifu
Su, Zhanliang
Shangguan, Junjie
Sun, Chong
Figini, Matteo
Wang, Jian
Yaghmai, Vahid
Larson, Andrew C.
Zhang, Zhuoli
author_sort Lyu, Tianchu
collection PubMed
description BACKGROUND: Liver cancer makes up a huge percentage of cancer mortality worldwide. Irreversible electroporation (IRE) is a relatively new minimally invasive nonthermal ablation technique for tumors that applies short pulses of high frequency electrical energy to irreversibly destabilize cell membrane to induce tumor cell apoptosis. METHODS: This review aims to investigate the studies regarding the use of IRE treatment in liver tumors and metastases to liver. We searched PubMed for all of IRE relevant English language articles published up to September 2016. They included clinical trials, experimental studies, observational studies, and reviews. This review manuscript is nothing with ethics issues and ethical approval is not provided. RESULTS: In recent years, increasingly more studies in both preclinical and clinical settings have been conducted to examine the safety and efficacy of this new technique, shedding light on the crucial advantages and disadvantages that IRE possesses. Unlike the current leading thermal ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, IRE requires shorter ablation time without damaging adjacent important vital structures. CONCLUSION: Although IRE has successfully claimed its valuable status in the field of hepatic cancer treatment both preclinical and clinical settings. In order to systemically test and establish its safety and efficacy for clinical applications, more studies still need to be conducted.
format Online
Article
Text
id pubmed-5413217
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-54132172017-05-05 Irreversible electroporation in primary and metastatic hepatic malignancies: A review Lyu, Tianchu Wang, Xifu Su, Zhanliang Shangguan, Junjie Sun, Chong Figini, Matteo Wang, Jian Yaghmai, Vahid Larson, Andrew C. Zhang, Zhuoli Medicine (Baltimore) 5700 BACKGROUND: Liver cancer makes up a huge percentage of cancer mortality worldwide. Irreversible electroporation (IRE) is a relatively new minimally invasive nonthermal ablation technique for tumors that applies short pulses of high frequency electrical energy to irreversibly destabilize cell membrane to induce tumor cell apoptosis. METHODS: This review aims to investigate the studies regarding the use of IRE treatment in liver tumors and metastases to liver. We searched PubMed for all of IRE relevant English language articles published up to September 2016. They included clinical trials, experimental studies, observational studies, and reviews. This review manuscript is nothing with ethics issues and ethical approval is not provided. RESULTS: In recent years, increasingly more studies in both preclinical and clinical settings have been conducted to examine the safety and efficacy of this new technique, shedding light on the crucial advantages and disadvantages that IRE possesses. Unlike the current leading thermal ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, IRE requires shorter ablation time without damaging adjacent important vital structures. CONCLUSION: Although IRE has successfully claimed its valuable status in the field of hepatic cancer treatment both preclinical and clinical settings. In order to systemically test and establish its safety and efficacy for clinical applications, more studies still need to be conducted. Wolters Kluwer Health 2017-04-28 /pmc/articles/PMC5413217/ /pubmed/28445252 http://dx.doi.org/10.1097/MD.0000000000006386 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 5700
Lyu, Tianchu
Wang, Xifu
Su, Zhanliang
Shangguan, Junjie
Sun, Chong
Figini, Matteo
Wang, Jian
Yaghmai, Vahid
Larson, Andrew C.
Zhang, Zhuoli
Irreversible electroporation in primary and metastatic hepatic malignancies: A review
title Irreversible electroporation in primary and metastatic hepatic malignancies: A review
title_full Irreversible electroporation in primary and metastatic hepatic malignancies: A review
title_fullStr Irreversible electroporation in primary and metastatic hepatic malignancies: A review
title_full_unstemmed Irreversible electroporation in primary and metastatic hepatic malignancies: A review
title_short Irreversible electroporation in primary and metastatic hepatic malignancies: A review
title_sort irreversible electroporation in primary and metastatic hepatic malignancies: a review
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413217/
https://www.ncbi.nlm.nih.gov/pubmed/28445252
http://dx.doi.org/10.1097/MD.0000000000006386
work_keys_str_mv AT lyutianchu irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT wangxifu irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT suzhanliang irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT shangguanjunjie irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT sunchong irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT figinimatteo irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT wangjian irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT yaghmaivahid irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT larsonandrewc irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview
AT zhangzhuoli irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview